EU backs return of banned drug

Europe’s drug regulators, the European Medicines Agench have recommended approval, January 2008, of thalidomide to treat bone marrow cancer, nearly 50 years after the medicine was withdrawn as a treatment for morning sickness around the world because it caused thousands of children to be born with birth defects.

European Medicines Agency: Press Release, 24.1.08: European Medicines Agency recommends the approval of thalidomide for the treatment of rare bone-marrow cancer http://www.emea.europa.eu/pdfs/human/press/pr/Pressrelease_Thalidomide3302408en.pdf

---